AbCellera Biologics, Inc. (ABCL)
3.68
+0.09
(+2.51%)
USD |
NASDAQ |
Dec 09, 16:00
3.70
+0.02
(+0.54%)
After-Hours: 06:07
AbCellera Biologics EPS Diluted (Quarterly): -0.1911 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Achieve Life Sciences, Inc. | -0.2831 |
| Oncolytics Biotech, Inc. | -0.1032 |
| Aurinia Pharmaceuticals, Inc. | 0.232 |
| Edesa Biotech, Inc. | -0.2491 |
| Lexaria Bioscience Corp. | -0.1378 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -57.12M |
| Revenue (Quarterly) | 8.955M |
| Total Expenses (Quarterly) | 66.07M |
| Enterprise Value | 723.10M |
| Gross Profit Margin (Quarterly) | 19.18% |
| Profit Margin (Quarterly) | -637.8% |
| Earnings Yield | -15.66% |
| Normalized Earnings Yield | -15.66 |